Emyria (ASX:EMD) said Non-Executive Chair Greg Hutchinson will assume the role of Executive Chairman, according to a Wednesday filing with the Australian bourse.
Chief Executive Officer Michael Winlo will transition into the new role of Chief Scientific Officer, reporting to the executive chairman, the filing said.
Shares of the company rose 9% at market close.